Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer.
Sunagawa Y, Yamada S, Sato Y, Morimoto D, Sonohara F, Takami H, Inokawa Y, Hayashi M, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y.
Sunagawa Y, et al. Among authors: sato y.
Ann Surg Oncol. 2020 Jun;27(6):2081-2089. doi: 10.1245/s10434-019-07981-w. Epub 2019 Oct 30.
Ann Surg Oncol. 2020.
PMID: 31673938